Skip to main content

Amanat Acquisition Corp 10-Q for FY2026 Q3

Amanat Acquisition Corp. (AMAN)

10-Q 2026-11-13 For: 2026-09-30
View Original
Added on November 13, 2026

About this 10-Q

Amanat Acquisition Corp filed this 10-Q on November 13, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

Amanat Acquisition Corp. agreed to combine with Corxel Pharmaceuticals, with closing expected in the first half of 2027. Management reported a $1,510,880 net loss from January 13, 2026 through September 30, 2026 and substantial doubt about its ability to continue as a going concern. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$1.48M